ENS 57110: Difference between revisions
Jump to navigation
Jump to search
StriderTol (talk | contribs) (StriderTol Bot change) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
| Line 15: | Line 15: | ||
| NRC officer = Adam Koziol | | NRC officer = Adam Koziol | ||
| event date = 05/06/2024 11:00 CDT | | event date = 05/06/2024 11:00 CDT | ||
| last update date = 07/ | | last update date = 07/10/2024 | ||
| title = Medical Event - Y-90 Overdose | | title = Medical Event - Y-90 Overdose | ||
| event text = The following information was provided by the licensee via telephone: | | event text = The following information was provided by the licensee via telephone: | ||
| Line 25: | Line 25: | ||
After further assessment of the event, it was discovered that the patient also received an unintended dose of 360 Gy Y-90 TheraSpheres to the lungs. No health effect or permanent functional damage is expected. | After further assessment of the event, it was discovered that the patient also received an unintended dose of 360 Gy Y-90 TheraSpheres to the lungs. No health effect or permanent functional damage is expected. | ||
Notified R3DO (Nguyen), NMSS Events Notification (email), NMSS Regional Coordinator (Sun) | Notified R3DO (Nguyen), NMSS Events Notification (email), NMSS Regional Coordinator (Sun) | ||
| URL = https://www.nrc.gov/reading-rm/doc-collections/event-status/event/2024/ | * * * UPDATE ON 7/10/24 AT 1250 EDT FROM JAMIE EISENBERG TO ERIC SIMPSON * * * | ||
The following information was provided by the licensee via telephone and email as a clarification to the July 9, 2024, update: | |||
The patient's Y-90 TheraSphere treatment resulted in an unintended dose to an organ/tissue other than the treatment site. The estimated intended dose was 0.9 Gy to the lungs. The estimated dose given the lungs was 3.29 Gy. The estimated overage was 2.39 Gy, which is 165 percent over the intended lung dose. | |||
This administration occurred on May 6, 2024, and was the second administration of the patient's regime. The previous treatment was on April 16, 2024, and was completed as intended. The patient's cumulative lung dose from both treatments was 4.2 Gy. The planned lung dose for the regime was 1.8 Gy, again showing the approximately 2.4 Gy overage from the May 6, 2024, administration. | |||
Notified R3DO (Nguyen), NMSS Events Notification (email), and NMSS Regional Coordinator (Sun) | |||
| URL = https://www.nrc.gov/reading-rm/doc-collections/event-status/event/2024/20240711en.html#en57110 | |||
}} | }} | ||
{{ENS-Nav}} | {{ENS-Nav}} | ||
Latest revision as of 07:20, 11 July 2024
| Where | |
|---|---|
| Saint Francis Medical Center Cape Girardeau, Missouri (NRC Region 3) | |
| License number: | 24-00158-03 |
| Organization: | Saint Francis Medical Center |
| Reporting | |
| 10 CFR 35.3045(a)(1) | |
| Time - Person (Reporting Time:+22.93 h0.955 days <br />0.136 weeks <br />0.0314 months <br />) | |
| Opened: | Jamie Eisenberg 14:56 May 7, 2024 |
| NRC Officer: | Adam Koziol |
| Last Updated: | Jul 10, 2024 |
| 57110 - NRC Website | |